Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

BUY
$0.66 - $1.4 $36,395 - $77,201
55,144 Added 251.01%
77,113 $77,000
Q2 2020

Aug 14, 2020

SELL
$0.59 - $1.12 $78,460 - $148,942
-132,984 Reduced 85.82%
21,969 $19,000
Q2 2019

Aug 09, 2019

BUY
$2.11 - $4.71 $244,527 - $545,841
115,890 Added 296.67%
154,953 $676,000
Q1 2019

May 14, 2019

BUY
$0.39 - $2.88 $15,234 - $112,501
39,063 New
39,063 $113,000
Q3 2018

Nov 13, 2018

SELL
$0.89 - $1.28 $15,079 - $21,687
-16,943 Closed
0 $0
Q2 2018

Aug 08, 2018

SELL
$1.22 - $1.79 $151,280 - $221,960
-124,000 Reduced 87.98%
16,943 $22,000
Q1 2018

May 07, 2018

BUY
$1.2 - $2.62 $81,600 - $178,160
68,000 Added 93.22%
140,943 $205,000
Q4 2017

Jan 17, 2018

SELL
$2.24 - $4.13 $86,367 - $159,240
-38,557 Reduced 34.58%
72,943 $174,000
Q3 2017

Nov 13, 2017

BUY
$3.35 - $3.96 $373,525 - $441,540
111,500
111,500 $393,000

Others Institutions Holding CFMS

About Conformis Inc


  • Ticker CFMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 187,856,992
  • Description
  • Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, a custom-made partial knee replacement option for either unicompartmental or bicompartmental osteoarthritis of the knee; iTotal CR, a cruc...
More about CFMS
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.